Abstract
1. The action of prenylamine, an antianginal drug, was studied in single ventricular guinea-pig myocytes. In concentrations of 10-50 microM, prenylamine significantly (P less than 0.01) shortened action potentials, and significantly (P less than 0.001) reduced the inward calcium current by 29% to 76% (n = 7). This effect was also present in the presence of adrenoceptor-blockade (with phentolamine and propranolol), and was thus not due to indirect changes in endogenous catecholamine action. 2. Prenylamine did not affect the steady state level of current at the end of long pulses, and does therefore not act by changing time-dependent outward currents. Since the resting potential in the unclamped mode is unchanged during gross changes in action potential duration, it is also unlikely that there are any changes in the background, time-independent potassium conductance. 3. It is concluded that prenylamine has a direct effect on cardiac calcium channels, not mediated by adrenoceptor activation.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Attwell D., Eisner D., Cohen I. Voltage clamp and tracer flux data: effects of a restricted extra-cellular space. Q Rev Biophys. 1979 Aug;12(3):213–261. doi: 10.1017/s0033583500005448. [DOI] [PubMed] [Google Scholar]
- Bourdillon P. D., Poole-Wilson P. A. The effects of verapamil, quiescence, and cardioplegia on calcium exchange and mechanical function in ischemic rabbit myocardium. Circ Res. 1982 Mar;50(3):360–368. doi: 10.1161/01.res.50.3.360. [DOI] [PubMed] [Google Scholar]
- Ehinger B., Sporrong B. Neuronal and extraneuronal localization of nonadrenaline in the rat heart after perfusion at high concentration. Experientia. 1968 Mar 15;24(3):265–266. doi: 10.1007/BF02152811. [DOI] [PubMed] [Google Scholar]
- Farnebo L. O., Malmfors T. Histochemical studies on the uptake of noradrenaline and alpha-methyl-noradrenaline in the perfused rat heart. Eur J Pharmacol. 1969 Mar;5(4):313–320. doi: 10.1016/0014-2999(69)90107-1. [DOI] [PubMed] [Google Scholar]
- Fedida D., Noble D., Shimoni Y., Spindler A. J. Inward current related to contraction in guinea-pig ventricular myocytes. J Physiol. 1987 Apr;385:565–589. doi: 10.1113/jphysiol.1987.sp016508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gelpi R. J., Mosca S. M., Rinaldi G. J., Kosoglov A., Cingolani H. E. Effect of calcium antagonism on contractile behavior of canine hearts. Am J Physiol. 1983 Mar;244(3):H378–H386. doi: 10.1152/ajpheart.1983.244.3.H378. [DOI] [PubMed] [Google Scholar]
- Göthert M., Nawroth P., Neumeyer H. Inhibitory effects of verapamil, prenylamine and D 600 on Ca2+-dependent noradrenaline release from the sympathetic nerves of isolated rabbit hearts. Naunyn Schmiedebergs Arch Pharmacol. 1979 Dec;310(1):11–19. doi: 10.1007/BF00499869. [DOI] [PubMed] [Google Scholar]
- Haas H. G., Kern R., Benninger C., Einwächter H. M. Effects of prenylamine on cardiac membrane currents and contractility. J Pharmacol Exp Ther. 1975 Mar;192(3):688–701. [PubMed] [Google Scholar]
- Higgins A. J., Blackburn K. J. Prevention of reperfusion damage in working rat hearts by calcium antagonists and calmodulin antagonists. J Mol Cell Cardiol. 1984 May;16(5):427–438. doi: 10.1016/s0022-2828(84)80614-8. [DOI] [PubMed] [Google Scholar]
- Lederer W. J., Tsien R. W. Transient inward current underlying arrhythmogenic effects of cardiotonic steroids in Purkinje fibres. J Physiol. 1976 Dec;263(2):73–100. doi: 10.1113/jphysiol.1976.sp011622. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marshall R. J., Parratt J. R. The haemodynamic and metabolic effects of MG 8926, a prospective antidysrhythmic and antianginal agent. Br J Pharmacol. 1977 Feb;59(2):311–322. doi: 10.1111/j.1476-5381.1977.tb07494.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Milei J., Vazquez A., Bolomo N. J. An overall review on prenylamine mechanisms of action in experimental models of myocardial damage. Cardiology. 1982;69(4):192–202. doi: 10.1159/000173504. [DOI] [PubMed] [Google Scholar]
- Nayler W. G., Ferrari R., Williams A. Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. Am J Cardiol. 1980 Aug;46(2):242–248. doi: 10.1016/0002-9149(80)90064-8. [DOI] [PubMed] [Google Scholar]
- Nayler W. G., Thompson J. E., Jarrott B. The interaction of calcium antagonists (slow channel blockers) with myocardial alpha adrenoceptors. J Mol Cell Cardiol. 1982 Mar;14(3):185–188. doi: 10.1016/0022-2828(82)90118-3. [DOI] [PubMed] [Google Scholar]
- Noble D. The surprising heart: a review of recent progress in cardiac electrophysiology. J Physiol. 1984 Aug;353:1–50. doi: 10.1113/jphysiol.1984.sp015320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Obianwu H. O. The effect of prenylamine (segontin) on the amine levels of brain, heart and adrenal medulla in rats. Acta Pharmacol Toxicol (Copenh) 1965;23(4):383–390. doi: 10.1111/j.1600-0773.1965.tb00362.x. [DOI] [PubMed] [Google Scholar]
- Powell T., Twist V. W. A rapid technique for the isolation and purification of adult cardiac muscle cells having respiratory control and a tolerance to calcium. Biochem Biophys Res Commun. 1976 Sep 7;72(1):327–333. doi: 10.1016/0006-291x(76)90997-9. [DOI] [PubMed] [Google Scholar]
- Sada H. Effect of phentolamine, alprenolol and prenylamine on maximum rate of rise of action potential in guinea-pig papillary muscles. Naunyn Schmiedebergs Arch Pharmacol. 1978 Oct;304(3):191–201. doi: 10.1007/BF00507958. [DOI] [PubMed] [Google Scholar]
- Sheridan D. J., Penkoske P. A., Sobel B. E., Corr P. B. Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats. J Clin Invest. 1980 Jan;65(1):161–171. doi: 10.1172/JCI109647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Watts J. A., Maiorano L. J., Maiorano P. C. Comparison of the protective effects of verapamil, diltiazem, nifedipine, and buffer containing low calcium upon global myocardial ischemic injury. J Mol Cell Cardiol. 1986 Mar;18(3):255–263. doi: 10.1016/s0022-2828(86)80407-2. [DOI] [PubMed] [Google Scholar]
- Winsor R., Bleifer K., Cole S., Goldman I. R., Karpman H., Oblath R., Stone S. A double-blind, double cross-over trial of prenylamine in angina pectoris. Am Heart J. 1971 Jul;82(1):43–54. doi: 10.1016/0002-8703(71)90160-8. [DOI] [PubMed] [Google Scholar]